US judge approves deal dissolving Purdue Pharma in opioid saga

US judge approves deal dissolving Purdue Pharma in opioid saga

Purdue Pharma, manufacturer of the OxyContin drug that has been blamed for the US opioid crisis, wil...
read more
Cuba approves two more locally made COVID vaccines

Cuba approves two more locally made COVID vaccines

Cuba on Friday approved two more domestic COVID-19...
read more
FDA Approves Saphnelo

FDA Approves Saphnelo

FDA Approves Saphnelo (anifrolumab) for Moderate t...
read more
FDA Approves Merck’s Keytruda (pembrolizumab) Combined With Trastuzumab and Chemotherapy as First-line Treatment in Locally Advanced Unresectable or Metastatic HER2-Positive Gastric or Gastroesophageal Junction Adenocarcinoma

FDA Approves Merck’s Keytruda (pembrolizumab) Combined With Trastuzumab and Chemotherapy as First-line Treatment in Locally Advanced Unresectable or Metastatic HER2-Positive Gastric or Gastroesophageal Junction Adenocarcinoma

KENILWORTH, N.J.–(BUSINESS WIRE) May 5, 2021...
read more
FDA approves immunotherapy for dMMR endometrial cancer

FDA approves immunotherapy for dMMR endometrial cancer

The anti-programmed death receptor 1 (PD-1) monoth...
read more
FDA approves ‘tongue strengthening’ device for certain sleep apnea patients

FDA approves ‘tongue strengthening’ device for certain sleep apnea patients

(HealthDay)—The U.S. Food and Drug Administratio...
read more
Canada Approves Pfizer COVID-19 Vaccine

Canada Approves Pfizer COVID-19 Vaccine

WEDNESDAY, Dec. 9, 2020 — The Pfizer COVID-1...
read more
FDA Approves Oxlumo

FDA Approves Oxlumo

FDA Approves Oxlumo (lumasiran) for the Treatment ...
read more
FDA Approves Trelegy Ellipta (fluticasone furoate/umeclidinium/vilanterol) for the Treatment of Asthma

FDA Approves Trelegy Ellipta (fluticasone furoate/umeclidinium/vilanterol) for the Treatment of Asthma

London UK 9 September 2020 — GlaxoSmithKline...
read more
FDA approves IV artesunate for severe malaria

FDA approves IV artesunate for severe malaria

Intravenous (IV) artesunate received approval from...
read more